Offner, F. Et Al. 2011. PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS). 11th International Conference on Malignant Lymphoma , (Lugano, Switzerland), 225.

Offner, F., Ferhanoglu, B., Reeves, J. A., Eom, H. S., Doner, K., Raposo, J., ... Flinn, I. W.(2011). PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS) . 11th International Conference on Malignant Lymphoma (pp.225). Lugano, Switzerland

Offner, F. Et Al. "PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS)," 11th International Conference on Malignant Lymphoma, Lugano, Switzerland, 2011

Offner, F. Et Al. "PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS)." 11th International Conference on Malignant Lymphoma , Lugano, Switzerland, pp.225, 2011

Offner, F. Et Al. (2011) . "PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS)." 11th International Conference on Malignant Lymphoma , Lugano, Switzerland, p.225.

@conferencepaper{conferencepaper, author={F. Offner Et Al. }, title={PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS)}, congress name={11th International Conference on Malignant Lymphoma}, city={Lugano}, country={Switzerland}, year={2011}, pages={225} }